UltraTech Cement (UTCEM) continued to improve its costs and margins in 1QFY22. It reported the highest ever EBITDA/unit of Rs 1,536/t (+8% YoY) during the quarter. Coupled with volume growth of 47% YoY, this led to 59% YoY growth in EBITDA.
Commenting on the result review, Motilal Oswal Institutional Equities said, "Market share gains should continue, aided by the ongoing 20mtpa expansion program, which should drive a 13% volume CAGR over FY21-24E.
We estimate a 15%/26% CAGR in consolidated EBITDA/PAT over FY21-23E, driven by a 13% volume CAGR, better realizations, lower operating costs, and lower interest costs.
The valuation is reasonable at 13.7x FY23E EV/EBITDA - a 10% discount to its last five years' average. We value UTCEM at 16x FY23E EV/EBITDA to arrive at TP of Rs 8,770. Reiterate Buy."
Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.
